ArticleClinical ophthalmology (Auckland, N.Z.)2024

Transitioning from Aflibercept to Biosimilar Ranibizumab in Neovascular AMD (The TRANSFORM Trial): A Multicenter Observational Study.

Debdulal Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.